MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib plus dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC). Meeting Abstract

Industry Collaboration

cited authors

  • Randall, Leslie M.; O'Malley, David M.; Monk, Bradley J.; Coleman, Robert L.; Gaillard, Stephanie; Adams, Sarah F.; Duska, Linda R.; Cappuccini, Fabio; Dalton, Heather; Holloway, Robert W.; Huang, Marilyn; Chon, Hye Sook; Cloven, Noelle Gillette; ElNaggar, Adam; O'Cearbhaill, Roisin Eilish; Waggoner, Steven E.; Wang, Zebin; Zhi, Eric; Samnotra, Vivek; Konstantinopoulos, Panagiotis A.

Publication Date

  • June 1, 2022

webpage

published in

category

volume

  • 40

issue

  • 16